This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
Open-source AI models have gone from niche developer tools to enterprise essentials almost overnight...
Decentralized Autonomous Organizations (DAOs) and other digital-native structures have moved from ni...
As the largest purchaser of goods and services in the world, the United States Government requires f...
Modern mediation increasingly brings together parties, counsel, and neutrals across a broad range of...
This program provides attorneys with a foundational understanding of derivatives and their role in m...
Estate planning for LGBTQ+ clients and families formed through assisted reproductive technology requ...
In Part 2, Mr. Kornblum will again use segments from the movies to teach pre-trial and trial tactics...
Have you felt overwhelmed by the amount of technology available to family lawyers? We'll get to know...
This program provides a practical roadmap to mastering every stage of the discovery process in civil...
Class action litigation continues to evolve rapidly in response to an innovative plaintiffs’ b...